AI to take center stage at 14th edition of LHIF in Bengaluru

The 14th edition of the Lifesciences & Healthcare Innovation Forum (LHIF) kicks off on April 16 at The Leela Palace, Bengaluru, under the theme “AI Disrupt: Transforming Diagnosis, Discovery and Delivery.” Organized by the MeitY-NASSCOM Center of Excellence, the event brings together top healthcare leaders, innovators, and policymakers to explore how artificial intelligence is revolutionizing the healthcare and pharmaceutical sectors.

Also Read: Amgen India MD Naveen Gullapalli to speak at 14th LHIF on AI Disruption in Healthcare

This year’s forum focuses on how AI is reshaping diagnosis through early detection tools, AI-powered imaging, and intelligent medical devices. On the discovery front, experts will highlight AI’s role in accelerating drug development, enhancing clinical trials, and leveraging Real World Evidence to drive innovation. In terms of delivery, discussions will centre on personalized care, digital healthcare platforms, and robotics to streamline treatment pathways.

Among the key topics are: “AI Inside: AI Empowered Medical Devices” and “How are LLMs/VLMs Reshaping Access to Care?”, which reflect the industry’s growing interest in large language and vision-language models.

Naveen Gullapalli, Managing Director of Amgen India, will be among the prominent speakers sharing insights on integrating AI into patient-centric solutions.

As AI continues to disrupt conventional paradigms, LHIF 2025 stands as a key platform for cross-sector collaboration aimed at building smarter, more responsive healthcare systems for the future.